IMV Inc IMVIF

RE:RE:RE:RE: WF

[TexasTea20]

Get all that. The WF guy was the only one that downgraded the stock as far as I know. I would argue that he is the one that didnt listen to what the company said. Rather he filled in his own gaps likely to support his own and his firms agenda. Based on the WF upgrade prior and that this last data clearly moved things along from a clinical perspective yeah I think its ok to vent on him. His reasoning, if that is infact what he really believes is flawed. No data for LD chemo supports a monotherapy argument that LD chemo is accounting for the clinical benefit. Honestly, thats just stupid.

This is ongoing, bits at a time. Nothing I saw warranted a downgrade. Arrows are pointing in the same obvious direction. 

Ever wonder about these analysts that cover multiple stocks, many competing with other stocks also covered by that same anylst, upgrading some downgrading others. At the end of the day these guys manage their own portfolios. Conflict of interests are likely rampant. Run one up the flagpole in the meantime knocking one down so as to facilitate and optimal or better entry or exit price. Its a dirty game if you ask me.

Clear path forward? Not completely clear but arrows point in the same direction. IMV are attempting to prove an overall thesis through all their trials. They are going to the FDA and will discuss a registration trial design and move on from there. Partnering potential is obvious with data maturing from all trials and coming in when it comes in. Wouldnt be surprised to see a partnering announcement before the end of Q2. There are no absolutes in this game but there is a preponderance of evidence if you choose to consider it.

IMV is massively undervalued in my eyes and yes this is on managment. These analysts clearly understand the milestones acheived and pending and how to manage/manipulate market activity and sentiment between it all. 

Onwards. Keep the faith. Have a great weekend. Im going skiing.